From BusinessLine

Center-Right Owned by The Hindu Group (Kasturi & Sons)

Cipla tops drug overcharging dues with ₹3,576 crore; J&J, Ranbaxy among top five

Published 02 Nov 2026, 22:09 IST

RSS excerpt

The government regulates the prices of certain medicines to prevent companies from charging patients more than the permitted amount

✦ Single Source 1 news outlet reporting

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Based on 1 reporting publisher

R 100%

Left / Center-Left 0 (0%)

Center 0 (0%)

Center-Right / Right 1 (100%)

06 Nov 2026, 02:12 IST Center

The Hans India

06 Nov 2026, 02:12 IST Center

The Hans India

06 Nov 2026, 02:08 IST Center

Rising Kashmir

06 Nov 2026, 02:07 IST Center

The Hans India

06 Nov 2026, 02:06 IST Center

YourStory

06 Nov 2026, 02:01 IST Center

The Hans India

06 Nov 2026, 02:01 IST Center

Rising Kashmir

06 Nov 2026, 02:00 IST Center

The Hans India

06 Nov 2026, 01:58 IST Center

Deccan Chronicle

✓ 2 outlets

06 Nov 2026, 01:56 IST Center